Literature DB >> 18791070

The human ERG1 channel polymorphism, K897T, creates a phosphorylation site that inhibits channel activity.

Saverio Gentile1, Negin Martin, Erica Scappini, Jason Williams, Christian Erxleben, David L Armstrong.   

Abstract

Single-nucleotide polymorphisms (SNPs) in the human ether-a-go-go-related gene 1, hERG1, are associated with cardiac arrhythmias. The Kv11.1 channels encoded by hERG1 are also essential for rhythmic excitability of the pituitary, where they are regulated by thyroid hormone through a signal transduction cascade involving the phosphatidylinositol 3-kinase (PI3K) and the Ser/Thr-directed protein phosphatase, PP5. Here, we show that the hERG1 polymorphism at codon 897, which is read as a Thr instead of a Lys, creates a phosphorylation site for the Akt protein kinase on the Kv11.1 channel protein. Consequently, hormonal signaling through the PI3K signaling cascade, which normally stimulates K897 channels through PP5-mediated dephosphorylation, inhibits T897 channels through Akt-mediated phosphorylation. Thus, hormonal regulation of Kv11.1 in humans with the T897 polymorphism is predicted to prolong the QT interval of cardiac myocytes. A systematic bioinformatics search for SNPs in human ion channel genes identified 15 additional candidates for such "phosphorylopathies," which are predicted to create or destroy putative phosphorylation sites. Changes in protein phosphorylation might represent a general mechanism for the interaction of genetic variation and environment on human health.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18791070      PMCID: PMC2567201          DOI: 10.1073/pnas.0802250105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  PI3K promotes voltage-dependent calcium channel trafficking to the plasma membrane.

Authors:  Patricia Viard; Adrian J Butcher; Guillaume Halet; Anthony Davies; Bernd Nürnberg; Fay Heblich; Annette C Dolphin
Journal:  Nat Neurosci       Date:  2004-08-15       Impact factor: 24.884

2.  Identification of two nervous system-specific members of the erg potassium channel gene family.

Authors:  W Shi; R S Wymore; H S Wang; Z Pan; I S Cohen; D McKinnon; J E Dixon
Journal:  J Neurosci       Date:  1997-12-15       Impact factor: 6.167

3.  Rapid vesicular translocation and insertion of TRP channels.

Authors:  Vassilios J Bezzerides; I Scott Ramsey; Suhas Kotecha; Anna Greka; David E Clapham
Journal:  Nat Cell Biol       Date:  2004-07-18       Impact factor: 28.824

4.  Molecular and functional characterization of common polymorphisms in HERG (KCNH2) potassium channels.

Authors:  Blake D Anson; Michael J Ackerman; David J Tester; Melissa L Will; Brian P Delisle; Corey L Anderson; Craig T January
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-02-19       Impact factor: 4.733

Review 5.  The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease.

Authors:  Gavin Y Oudit; Hui Sun; Benoit-Gilles Kerfant; Michael A Crackower; Josef M Penninger; Peter H Backx
Journal:  J Mol Cell Cardiol       Date:  2004-08       Impact factor: 5.000

6.  Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism.

Authors:  Igor Splawski; Katherine W Timothy; Leah M Sharpe; Niels Decher; Pradeep Kumar; Raffaella Bloise; Carlo Napolitano; Peter J Schwartz; Robert M Joseph; Karen Condouris; Helen Tager-Flusberg; Silvia G Priori; Michael C Sanguinetti; Mark T Keating
Journal:  Cell       Date:  2004-10-01       Impact factor: 41.582

7.  HERG, a human inward rectifier in the voltage-gated potassium channel family.

Authors:  M C Trudeau; J W Warmke; B Ganetzky; G A Robertson
Journal:  Science       Date:  1995-07-07       Impact factor: 47.728

8.  A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome.

Authors:  M E Curran; I Splawski; K W Timothy; G M Vincent; E D Green; M T Keating
Journal:  Cell       Date:  1995-03-10       Impact factor: 41.582

9.  Transfer of rapid inactivation and sensitivity to the class III antiarrhythmic drug E-4031 from HERG to M-eag channels.

Authors:  I M Herzberg; M C Trudeau; G A Robertson
Journal:  J Physiol       Date:  1998-08-15       Impact factor: 5.182

10.  Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine.

Authors:  E H Walker; M E Pacold; O Perisic; L Stephens; P T Hawkins; M P Wymann; R L Williams
Journal:  Mol Cell       Date:  2000-10       Impact factor: 17.970

View more
  17 in total

Review 1.  Methods, Tools and Current Perspectives in Proteogenomics.

Authors:  Kelly V Ruggles; Karsten Krug; Xiaojing Wang; Karl R Clauser; Jing Wang; Samuel H Payne; David Fenyö; Bing Zhang; D R Mani
Journal:  Mol Cell Proteomics       Date:  2017-04-29       Impact factor: 5.911

2.  Relationship of common candidate gene variants to electrocardiographic T-wave peak to T-wave end interval and T-wave morphology parameters.

Authors:  Kimmo Porthan; Annukka Marjamaa; Matti Viitasalo; Heikki Väänänen; Antti Jula; Lauri Toivonen; Markku S Nieminen; Christopher Newton-Cheh; Veikko Salomaa; Kimmo Kontula; Lasse Oikarinen
Journal:  Heart Rhythm       Date:  2010-03-04       Impact factor: 6.343

Review 3.  Classification and Reporting of Potentially Proarrhythmic Common Genetic Variation in Long QT Syndrome Genetic Testing.

Authors:  John R Giudicessi; Dan M Roden; Arthur A M Wilde; Michael J Ackerman
Journal:  Circulation       Date:  2018-02-06       Impact factor: 29.690

4.  PhosSNP for systematic analysis of genetic polymorphisms that influence protein phosphorylation.

Authors:  Jian Ren; Chunhui Jiang; Xinjiao Gao; Zexian Liu; Zineng Yuan; Changjiang Jin; Longping Wen; Zhaolei Zhang; Yu Xue; Xuebiao Yao
Journal:  Mol Cell Proteomics       Date:  2009-12-08       Impact factor: 5.911

Review 5.  Control of cardiac repolarization by phosphoinositide 3-kinase signaling to ion channels.

Authors:  Lisa M Ballou; Richard Z Lin; Ira S Cohen
Journal:  Circ Res       Date:  2015-01-02       Impact factor: 17.367

6.  Torsades de pointes following acute myocardial infarction: evidence for a deadly link with a common genetic variant.

Authors:  Lia Crotti; Dan Hu; Hector Barajas-Martinez; Gaetano M De Ferrari; Antonio Oliva; Roberto Insolia; Guido D Pollevick; Federica Dagradi; Alejandra Guerchicoff; Federica Greco; Peter J Schwartz; Sami Viskin; Charles Antzelevitch
Journal:  Heart Rhythm       Date:  2012-02-13       Impact factor: 6.343

Review 7.  KCNH2 pharmacogenomics summary.

Authors:  Connie Oshiro; Caroline F Thorn; Dan M Roden; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2010-12       Impact factor: 2.089

8.  Characterization of Plasma Membrane Localization and Phosphorylation Status of Organic Anion Transporting Polypeptide (OATP) 1B1 c.521 T>C Nonsynonymous Single-Nucleotide Polymorphism.

Authors:  Alexandra Crowe; Wei Zheng; Jonathan Miller; Sonia Pahwa; Khondoker Alam; Kar-Ming Fung; Erin Rubin; Feng Yin; Kai Ding; Wei Yue
Journal:  Pharm Res       Date:  2019-05-15       Impact factor: 4.200

9.  Identification of IDUA and WNT16 Phosphorylation-Related Non-Synonymous Polymorphisms for Bone Mineral Density in Meta-Analyses of Genome-Wide Association Studies.

Authors:  Tianhua Niu; Ning Liu; Xun Yu; Ming Zhao; Hyung Jin Choi; Paul J Leo; Matthew A Brown; Lei Zhang; Yu-Fang Pei; Hui Shen; Hao He; Xiaoying Fu; Shan Lu; Xiang-Ding Chen; Li-Jun Tan; Tie-Lin Yang; Yan Guo; Nam H Cho; Jie Shen; Yan-Fang Guo; Geoffrey C Nicholson; Richard L Prince; John A Eisman; Graeme Jones; Philip N Sambrook; Qing Tian; Xue-Zhen Zhu; Christopher J Papasian; Emma L Duncan; André G Uitterlinden; Chan Soo Shin; Shuanglin Xiang; Hong-Wen Deng
Journal:  J Bone Miner Res       Date:  2015-09-11       Impact factor: 6.741

10.  Activated Rac1 GTPase translocates protein phosphatase 5 to the cell membrane and stimulates phosphatase activity in vitro.

Authors:  Anindya Chatterjee; Ling Wang; David L Armstrong; Sandra Rossie
Journal:  J Biol Chem       Date:  2009-11-30       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.